Minimizing Inappropriate Medications in Older Populations: A 10-step Conceptual Framework

被引:80
作者
Scott, Ian A. [1 ]
Gray, Leonard C.
Martin, Jennifer H. [2 ]
Mitchell, Charles A. [3 ]
机构
[1] Princess Alexandra Hosp, Dept Internal Med & Clin Epidemiol, Brisbane, Qld 4102, Australia
[2] Univ Queensland, So Sch Med, Brisbane, Qld, Australia
[3] Univ Queensland, Ctr Safe & Effect Prescribing, Brisbane, Qld, Australia
关键词
Inappropriate use; Medication; Minimization framework; Older populations; ADVERSE DRUG EVENTS; FRACTURE INTERVENTION TRIAL; ELDERLY-PATIENTS; RISK-FACTORS; DECISION-MAKING; BEERS CRITERIA; HEART-FAILURE; HOSPITALIZED-PATIENTS; MULTIPLE MEDICATIONS; ATRIAL-FIBRILLATION;
D O I
10.1016/j.amjmed.2011.09.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increasing burden of harm resulting from the use of multiple drugs in older patient populations represents a major health problem in developed countries. Approximately 1 in 4 older patients admitted to hospitals are prescribed at least 1 inappropriate medication, and up to 20% of all inpatient deaths are attributable to potentially preventable adverse drug reactions. To minimize this drug-related iatrogenesis, we propose a quality use of medicine framework that comprises 10 sequential steps: 1) ascertain all current medications; 2) identify patients at high risk of or experiencing adverse drug reactions; 3) estimate life expectancy in high-risk patients; 4) define overall care goals in the context of life expectancy; 5) define and confirm current indications for ongoing treatment; 6) determine the time until benefit for disease-modifying medications; 7) estimate the magnitude of benefit versus harm in relation to each medication; 8) review the relative utility of different drugs; 9) identify drugs that may be discontinued; and 10) implement and monitor a drug minimization plan with ongoing reappraisal of drug utility and patient adherence by a single nominated clinician. The framework aims to reduce drug use in older patients to the minimum number of essential drugs, and its utility is demonstrated in reference to a hypothetic case study. Further studies are warranted in validating this framework as a means for assisting clinicians to make more appropriate prescribing decisions in at-risk older patients. (C) 2012 Elsevier Inc. All rights reserved. . The American Journal of Medicine (2012) 125, 529-537
引用
收藏
页码:529 / +
页数:13
相关论文
共 79 条
[1]   The value of inpatient pharmaceutical counselling to elderly patients prior to discharge [J].
Al-Rashed, SA ;
Wright, DJ ;
Roebuck, N ;
Sunter, W ;
Chrystyn, H .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (06) :657-664
[2]   The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial [J].
Ballard, Clive ;
Hanney, Maria Luisa ;
Theodoulou, Megan ;
Douglas, Simon ;
McShane, Rupert ;
Kossakowski, Katja ;
Gill, Randeep ;
Juszczak, Edmund ;
Yu, Ly-Mee ;
Jacoby, Robin .
LANCET NEUROLOGY, 2009, 8 (02) :151-157
[3]   Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients [J].
Barry, P. J. ;
O'Keefe, N. ;
O'Connor, K. A. ;
O'Mahony, D. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (06) :617-626
[4]   Interventions to Improve Medication Reconciliation in Primary Care [J].
Bayoumi, Imaan ;
Howard, Michelle ;
Holbrook, Anne M. ;
Schabort, Inge .
ANNALS OF PHARMACOTHERAPY, 2009, 43 (10) :1667-1675
[5]   Treatment of hypertension in patients 80 years of age or older [J].
Beckett, Nigel S. ;
Peters, Ruth ;
Fletcher, Astrid E. ;
Staessen, Jan A. ;
Liu, Lisheng ;
Dumitrascu, Dan ;
Stoyanovsky, Vassil ;
Antikainen, Riitta L. ;
Nikitin, Yuri ;
Anderson, Craig ;
Belhani, Alli ;
Forette, Francoise ;
Rajkumar, Chakravarthi ;
Thijs, Lutgarde ;
Banya, Winston ;
Bulpitt, Christopher J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) :1887-1898
[6]   Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies [J].
Beijer, HJM ;
de Blaey, CJ .
PHARMACY WORLD & SCIENCE, 2002, 24 (02) :46-54
[7]   Providing patient care in community pharmacies in Australia [J].
Benrimoj, SI ;
Roberts, AS .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (11) :1911-1917
[8]  
Berthold HK, 2011, CURR PHARM DESIGN, V17, P877
[9]   Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938
[10]   Are elderly patients with diabetes being overtreated in French long-term-care homes? [J].
Bouillet, B. ;
Valliant, G. ;
Petit, J. -M. ;
Duclos, M. ;
Poussier, A. ;
Brindisi, M. C. ;
Verges, B. .
DIABETES & METABOLISM, 2010, 36 (04) :272-277